Evidence map›Paper›PMID 38589931›Full record

ArticleJournal of medical case reports2024

Documentation of a novel FBP1 gene mutation in the Arabian ethnicity: a case report.

Maher Almousa, Mohammad Aljomaa, Shekhey Hamey, Diana Alasmar

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Maher AlmousaFaculty of Medicine, Hama University, Hama, Syria. maher.almousa@syssr.org.
Mohammad AljomaaDepartment of Gastroenterology, Aleppo University Hospital, University of Aleppo, Aleppo, Syria.
Shekhey HameyFaculty of Medicine, Damascus University, Damascus, Syria.
Diana AlasmarDepartment of Pediatrics, University Children Hospital, Damascus University, Damascus, Syria.
Damascus University · SYHoms University · SYUniversity of Aleppo · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFructose-1,6-bisphosphatase deficiency is a rare autosomal recessive disorder characterized by impaired gluconeogenesis. Fructose-1,6-bisphosphatase 1 (FBP1) mutations demonstrate ethnic patterns. For instance, Turkish populations commonly harbor exon 2 deletions. We present a case report of whole exon 2 deletion in a Syrian Arabian child as the first recording of this mutation among Arabian ethnicity and the first report of FBP1 gene mutation in Syria. CASE PRESENTATION: We present the case of a 2.5-year-old Syrian Arab child with recurrent hypoglycemic episodes, accompanied by nausea and lethargy. The patient's history, physical examination, and laboratory findings raised suspicion of fructose-1,6-bisphosphatase deficiency. Whole exome sequencing was performed, revealing a homozygous deletion of exon 2 in the FBP1 gene, confirming the diagnosis.

conclusionThis case highlights a potential novel mutation in the Arab population; this mutation is well described in the Turkish population, which suggests potential shared mutations due to ancestral relationships between the two ethnicities. Further studies are needed to confirm this finding.

Indexed as

Fructose-1,6-Diphosphatase DeficiencyChild, PreschoolDocumentationEthnicityFructoseFructose-BisphosphataseHomozygoteHumansMutationSequence DeletionFructoseFructose-BisphosphataseArab populationCase reportFBP1 geneFructose-1,6-bisphosphatase deficiencyGluconeogenesisNovel mutation

Identifiers

PMID38589931
PMCPMC11002998
OpenAlexW4394739948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.